RADICAVA ORS
Live / Registered — Registered (as of 20 Jun 2023)
What this means for you
Registered since 20 Jun 2023. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 20 Jun 2029: the §71 affidavit of use).
Record
- Serial number
- 79334971
- Registration number
- 7082599
- Mark type
- Design + words
- Filed
- 23 Dec 2021
- Published for opposition
- 04 Apr 2023
- Registered
- 20 Jun 2023
- Next maintenance filing
- §71 affidavit of use, due by 20 Jun 2029 (grace period to 20 Dec 2029)
- Attorney of record
- Jeffrey L. Costellia
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical preparations for protection against free radicals; pharmaceutical preparations for removing free radicals from the human bodies; neuroprotective medicines; pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis (ALS)
Owner
Prosecution history
- 18 Dec 2025 — CHANGE OF OWNER RECEIVED FROM IB
- 16 Oct 2023 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 22 Sept 2023 — FINAL DISPOSITION NOTICE SENT TO IB
- 22 Sept 2023 — FINAL DISPOSITION PROCESSED
- 20 Sept 2023 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 20 Jun 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 20 Jun 2023 — REGISTERED-PRINCIPAL REGISTER
- 04 Apr 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 04 Apr 2023 — PUBLISHED FOR OPPOSITION
- 15 Mar 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 Feb 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 23 Feb 2023 — EXAMINER'S AMENDMENT ENTERED
- 23 Feb 2023 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 23 Feb 2023 — EXAMINERS AMENDMENT E-MAILED
- 23 Feb 2023 — EXAMINERS AMENDMENT -WRITTEN